Since BUB1 expression directly correlates with p53 (TP53; [46]), we will investigate a potentially synthetic lethal relationship between BUB1 inhibition and TP53 mutations that could help identify biomarkers that predict sensitivity to BUB1 inhibitors in TP53-mutant cancers including in lung cancers. The gene discussed is TP53; the disease is cancer.